Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$641,611
+$16,253 QoQ
Shares Held
4,094
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#785
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 32%
Shared 68%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Partners, LLC holds $5,444,856 across 5 Drug Manufacturers - General names. NVS ranks #3 (11.8% of the industry book) .
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $641,611 | 4,094 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $625,358 | 4,094 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $559,890 | 4,061 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $520,782 | 4,061 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $491,421 | 4,061 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $452,720 | 4,061 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $395,175 | 4,061 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||